Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MoonLake Immunotherapeutics (MLTX) Cash from Operations (2021 - 2026)

MoonLake Immunotherapeutics' Cash from Operations history spans 6 years, with the latest figure at 66286000.0 for Q1 2026.

  • Quarterly Cash from Operations fell 73.8% to 66286000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 224153000.0 through Mar 2026, down 60.36% year-over-year, with the annual reading at 196007000.0 for FY2025, 68.12% down from the prior year.
  • Cash from Operations came in at 66286000.0 for Q1 2026, down from 58794000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 9024427.0 in Q1 2023 to a low of 66286000.0 in Q1 2026.
  • The 5-year median for Cash from Operations is 20760383.0 (2022), against an average of 28091288.24.
  • The largest YoY upside for Cash from Operations was 67.03% in 2022 against a maximum downside of 13060.13% in 2022.
  • MoonLake Immunotherapeutics' Cash from Operations stood at 11595982.0 in 2022, then decreased by 6.45% to 12344159.0 in 2023, then tumbled by 292.68% to 48473000.0 in 2024, then fell by 21.29% to 58794000.0 in 2025, then dropped by 12.74% to 66286000.0 in 2026.
  • Per Business Quant, the three most recent readings for MLTX's Cash from Operations are 66286000.0 (Q1 2026), 58794000.0 (Q4 2025), and 44543000.0 (Q3 2025).